Recalls / Firms / Boehringer Ingelheim Roxane Inc

Boehringer Ingelheim Roxane Inc

15 FDA drug recalls on record.

Date	Class	Drug	Status
2015-09-25	Class III	Furosemide	Terminated
2015-09-25	Class III	Furosemide	Terminated
2015-07-24	Class II	Combivent Respimat	Terminated
2015-04-02	Class II	Acarbose	Completed
2014-07-28	Class III	OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringe	Terminated
2014-05-01	Class II	Calcitriol	Terminated
2014-04-04	Class III	Mercaptopurine	Terminated
2014-04-04	Class III	Azathioprine Tablets USP, 50 mg, 100 count bottle, Rx only, Roxanne Laboratories, Inc., Co	Terminated
2014-03-27	Class III	Spiriva	Terminated
2013-08-30	Class III	Spiriva	Terminated
2013-06-14	Class III	Prednisone	Terminated
2013-04-03	Class II	Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim,	Terminated
2013-03-18	Class III	Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters	Terminated
2012-12-12	Class III	Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim,	Terminated
2012-11-05	Class II	Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by	Terminated